20 results on '"Karim Sultan Haider"'
Search Results
2. 378 Improvement of Erectile Function in Hypogonadal Men Receiving Long-term Treatment with Testosterone Compared to a Hypogonadal Control Group: 7116 Patient-years of Clinical Experience
3. 099 Erectile Function Improves in Hypogonadal Men with Type 2 Diabetes Under Long-term Testosterone Therapy: Real-world Evidence from a Urological Registry Study
4. 090 Reduction of Major Adverse Cardiovascular Events (MACE) and Improvement of Erectile Function in Hypogonadal Men Receiving Testosterone Therapy – Real-life Evidence from a Registry Study
5. 097 In Obese Hypogonadal Men, Long-term Testosterone Therapy Improves Erectile Function, Quality of Life and Body Weight – Real-life Evidence from a Registry Study
6. 105 Improvement of Type 2 Diabetes (T2DM) in Hypogonadal Men receiving Long-term Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office
7. 013 Mortality, Incident Myocardial Infarction and Stroke in Hypogonadal Men with a Pre-Existing Cardiovascular Disease with and without Testosterone Therapy: Real-Life Evidence from a 10-Year Registry
8. 230 Glucose, Glycated Hemoglobin A levels and Erectile Function in 16 Hypogonadal Men with Type 2 Diabetes (T2DM) before and after Testosterone Therapy
9. 132 Erectile and Urinary Function and Quality of Life Improve in Hypogonadal Men with Osteoporosis under Long-Term Testosterone Therapy with Testosterone Undecanoate Injections (TU) in Comparison to an Untreated Control Group: 10-Year Data from a Registry St
10. PS-07-006 Erectile Function in 151 Hypogonadal Men with Pre-Existing Cardiovascular Disease (CVD) Improves Over 8 Years with Testosterone Undecanoate Injections (TU) in Comparison to an Untreated Control Group
11. 132 Long-Term Testosterone Treatment Leads to Sustained Weight Loss in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study
12. 130 Long-term Testosterone Treatment Improves Glycemic Control in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study
13. 131 Prostate Cancer Incidence and Severity in Testosterone-treated vs. Untreated Hypogonadal Men: Real-life Experience from more than 5500 Patients Years
14. 001 Urinary and Sexual Function in 411 Obese Hypogonadal Men with and Without Testosterone Therapy: Real-Life Evidence from a 10-Registry Study in a Urological Office
15. PS-08-011 77 Men with Pre-Existing Cardiovascular Disease (CVD) and Hypogonadism Show Improved Erectile Function on Long-Term Treatment with Testosterone Undecanoate Injections (TU)
16. HP-03-002 Erectile Function in 164 Propensity-Matched Hypogonadal Men from A Registry with or without Treatment with Testosterone Undecanoate Injections (TU) for up to 8 Years
17. PS-08-010 Improvement of Erectile Function in 225 Hypogonadal Men with Type 2 Diabetes (T2DM) Over 8 Years with Testosterone Undecanoate Injections (TU) in Comparison to an Untreated Control Group
18. 016 Long-term Testosterone Treatment Improves Urinary and Sexual Function in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study
19. 005 Erectile Function in 164 Matched Hypogonadal Men: Results of Long Term Treatment with Testosterone Undecanoate Injections (TU) in Comparison with Control Group
20. HP-09-001 Erectile Function and Glycaemic Control in 109 Hypogonadal Men with Prediabetes Treated with Testosterone Undecanoate Injections (TU) for up to 8 Years: Real-life Data from Registry Studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.